Evaluation of a bioluminescent mouse model expressing aromatase PII-promoter-controlled luciferase as a tool for the study of endocrine disrupting chemicals.
In conclusion, differences in estrogen levels due to polymorphism at the aromataseCYP19 gene may predispose men to increased age-related bone loss and fracture risk.